Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20060271163 A1
Publication typeApplication
Application numberUS 11/417,651
Publication dateNov 30, 2006
Filing dateMay 3, 2006
Priority dateMar 4, 1998
Also published asCN1301139A, DE69831608D1, DE69831608T2, EP1059893A1, EP1059893A4, EP1059893B1, US6077296, US6331190, US20020147492, US20040204753, US20070112412, WO1999044536A1
Publication number11417651, 417651, US 2006/0271163 A1, US 2006/271163 A1, US 20060271163 A1, US 20060271163A1, US 2006271163 A1, US 2006271163A1, US-A1-20060271163, US-A1-2006271163, US2006/0271163A1, US2006/271163A1, US20060271163 A1, US20060271163A1, US2006271163 A1, US2006271163A1
InventorsMehrdad Shokoohi, Michael Henson, Gerard Hoffmann
Original AssigneeShokoohi Mehrdad M, Henson Michael R, Hoffmann Gerard V
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Endoluminal vascular prosthesis
US 20060271163 A1
Abstract
Disclosed is a tubular endoluminal vascular prosthesis, useful in treating, for example, an abdominal aortic aneurysm. The prosthesis comprises a self expandable wire support structure surrounded by a flexible tubular membrane. A delivery catheter and methods are also disclosed.
Images(13)
Previous page
Next page
Claims(34)
1. An endoluminal prosthesis, comprising:
a tubular wire support having a proximal end, a distal end and a central lumen extending therethrough;
the wire support comprising at least a first and a second axially adjacent tubular segment, joined by a connector extending therebetween;
wherein the first and second segments and the connector are formed from a single length of wire.
2. An endoluminal prosthesis as in claim 1, comprising at least three segments and two connectors.
3. An endoluminal prosthesis as in claim 1, comprising at least five segments and four connectors.
4. An endoluminal prosthesis as in claim 1, wherein the wire in each segment comprises a series of proximal bends, a series of distal bends, creating a series of strut segments connecting the proximal bends and distal bends to form a tubular segment wall.
5. An endoluminal prosthesis as in claim 4, wherein at least some of the strut segments are substantially linear.
6. An endoluminal prosthesis as in claim 4, further comprising an eye on at least some of the bends.
7. An endoluminal prosthesis as in claim 6, wherein one or more eyes on a distal end of the first tubular segment are connected to one or more corresponding eyes on a proximal end of the second tubular segment.
8. An endoluminal prosthesis as in claim 7, wherein the corresponding eyes are connected with a suture, or ring.
9. An endoluminal prosthesis as in claim 4, wherein each segment comprises from about 4 proximal bends to about 12 proximal bends.
10. An endoluminal prosthesis as in claim 1, having at least a proximal segment, an intermediate segment and a distal segment, wherein the prosthesis is expandable from a reduced cross section to an expanded cross section.
11. An endoluminal prosthesis as in claim 10, wherein at least a portion of the proximal segment and distal segment is larger in cross section than the central segment when the prosthesis is in the expanded cross section.
12. An endoluminal prosthesis as in claim 1, further comprising a polymeric layer on the wire support.
13. An endoluminal prosthesis as in claim 12, wherein the layer comprises a tubular PTFE sleeve surrounding at least a central portion of the prosthesis.
14. A method of making an endoluminal prosthesis, comprising the steps of:
providing a length of wire;
forming the wire into two or more zig-zag sections, each zig-zag section separated by a crosslink;
rolling the formed wire about an axis to produce a series of tubular elements positioned along the axis such that each tubular element is connected to the adjacent tubular element by a link.
15. A method as in claim 14, further comprising the step of positioning a tubular polymeric sleeve concentrically on at least one of the tubular elements.
16. A method as in claim 15, wherein the positioning step comprises positioning the tubular polymeric sleeve concentrically on the outside surface of the tubular element.
17. A method as in claim 16, wherein the tubular polymeric sleeve comprises PTFE.
18. A multizone endoluminal prosthesis, comprising:
a tubular wire support having a proximal end, a distal end, and a central lumen extending therethrough;
the wire support comprising at least a first and a second axially adjacent tubular segments, joined by a connector extending therebetween;
wherein the first tubular segment has a different radial strength than the second tubular segment.
19. An endoluminal prosthesis as in claim 18, further comprising a third tubular segment, wherein at least one of the tubular segments has a different radial strength than the other two tubular segments.
20. An endoluminal prosthesis as in claim 19, wherein a proximal end of the prosthesis is self expandable to a greater diameter than a central region of the prosthesis.
21. An endoluminal prosthesis, comprising an elongate flexible wire, formed into a plurality of axially adjacent tubular segments spaced along an axis, each tubular segment comprising a zig zag section of the wire, having a plurality of proximal bends and distal bends, with the wire continuing between each adjacent tubular segment, wherein the prosthesis is radially compressible into a first, reduced cross sectional configuration for implantation into a body lumen, and self expandable to a second, enlarged cross sectional configuration at a treatment site in a body lumen.
22. An endoluminal prosthesis as in claim 21, comprising at least three segments formed from said wire.
23. An endoluminal prosthesis as in claim 22, further comprising an outer tubular sleeve surrounding at least a portion of the prosthesis.
24. An endoluminal prosthesis as in claim 23, wherein the sleeve further comprises at least one lateral perfusion port extending therethrough.
25. An endoluminal prosthesis as in claim 22, wherein the prosthesis has a proximal end and a distal end, and at least one of the proximal end and distal end as expandable to a larger diameter than a central section of the prosthesis in an unconstrained expansion.
26. An endoluminal prosthesis as in claim 21, wherein at least one distal bend on a first segment is connected to at least one proximal bend from an adjacent segment.
27. An endoluminal prosthesis as in claim 26, wherein the connection comprises a pivotable connection.
28. An endoluminal prosthesis as in claim 27, wherein the connection comprises a metal link.
29. An endoluminal prosthesis as in claim 27, wherein the connection comprises a suture.
30. An endoluminal prosthesis as in claim 21, wherein the prosthesis has an expansion ratio of at least about 1:4.
31. An endoluminal prosthesis as in claim 30, wherein the prosthesis has an expansion ratio of at least about 1:5.
32. An endoluminal prosthesis as in claim 21, wherein the prosthesis has an expanded diameter of at least about 20 mm-30 mm in an unconstrained expansion, and the prosthesis is implantable using a catheter no greater than about 16 French.
33. A prosthesis as in claim 32, wherein the prosthesis has an expanded diameter of at least about 25 mm, and is implantable on a delivery device having a diameter of no more than about 16 French.
34. A method of implanting an endoluminal vascular prosthesis, comprising the steps of:
providing a self expandable endoluminal vascular prosthesis, having a proximal end, a distal end and a central lumen extending therethrough, said prosthesis expandable from a first, reduced diameter to a second, enlarged diameter;
mounting the prosthesis on a catheter, such that when the prosthesis is in the reduced diameter configuration on the catheter, the catheter diameter through the prosthesis is no more than about 16 French;
introducing the catheter into a body lumen, and positioning the prosthesis at a treatment site in the body lumen;
releasing the prosthesis at the treatment site, such that the prosthesis expands from the first diameter to the second diameter;
wherein the second diameter is at least about 20 mm.
Description
  • [0001]
    This application is a continuation of U.S. application Ser. No. 09/034,689 filed on Mar. 4, 1998.
  • BACKGROUND OF THE INVENTION
  • [0002]
    The present invention relates to endoluminal vascular prostheses, and, in one application, to self-expanding endoluminal vascular prostheses for use in the treatment of abdominal aortic aneurysms.
  • [0003]
    An abdominal aortic aneurysm is a sac caused by an abnormal dilation of the wall of the aorta, a major artery of the body, as it passes through the abdomen. The abdomen is that portion of the body which lies between the thorax and the pelvis. It contains a cavity, known as the abdominal cavity, separated by the diaphragm from the thoracic cavity and lined with a serous membrane, the peritoneum. The aorta is the main trunk, or artery, from which the systemic arterial system proceeds. It arises from the left ventricle of the heart, passes upward, bends over and passes down through the thorax and through the abdomen to about the level of the fourth lumbar vertebra, where it divides into the two common iliac arteries.
  • [0004]
    The aneurysm usually arises in the infrarenal portion of the diseased aorta, for example, below the kidneys. When left untreated, the aneurysm may eventually cause rupture of the sac with ensuing fatal hemorrhaging in a very short time. High mortality associated with the rupture led initially to transabdominal surgical repair of abdominal aortic aneurysms. Surgery involving the abdominal wall, however, is a major undertaking with associated high risks. There is considerable mortality and morbidity associated with this magnitude of surgical intervention, which in essence involves replacing the diseased and aneurysmal segment of blood vessel with a prosthetic device which typically is a synthetic tube, or graft, usually fabricated of Polyester, Urethane, P, DACRON®, TEFLON®, or other suitable material.
  • [0005]
    To perform the surgical procedure requires exposure of the aorta through an abdominal incision which can extend from the rib cage to the pubis. The aorta must be closed both above and below the aneurysm, so that the aneurysm can then be opened and the thrombus, or blood clot, and arteriosclerotic debris removed. Small arterial branches from the back wall of the aorta are tied off. The DACRON® tube, or graft, of approximately the same size of the normal aorta is sutured in place, thereby replacing the aneurysm. Blood flow is then reestablished through the graft. It is necessary to move the intestines in order to get to the back wall of the abdomen prior to clamping off the aorta.
  • [0006]
    If the surgery is performed prior to rupturing of the abdominal aortic aneurysm, the survival rate of treated patients is markedly higher than if the surgery is performed after the aneurysm ruptures, although the mortality rate is still quite high. If the surgery is performed prior to the aneurysm rupturing, the mortality rate is typically slightly less than 10%. Conventional surgery performed after the rupture of the aneurysm is significantly higher, one study reporting a mortality rate of 66.5%. Although abdominal aortic aneurysms can be detected from routine examinations, the patient does not experience any pain from the condition. Thus, if the patient is not receiving routine examinations, it is possible that the aneurysm will progress to the rupture stage, wherein the mortality rates are significantly higher.
  • [0007]
    Disadvantages associated with the conventional, prior art surgery, in addition to the high mortality rate include the extended recovery period associated with such surgery; difficulties in suturing the graft, or tube, to the aorta; the loss of the existing aorta wall and thrombosis to support and reinforce the graft; the unsuitability of the surgery for many patients having abdominal aortic aneurysms; and the problems associated with performing the surgery on an emergency basis after the aneurysm has ruptured. A patient can expect to spend from one to two weeks in the hospital after the surgery, a major portion of which is spent in the intensive care unit, and a convalescence period at home from two to three months, particularly if the patient has other illnesses such as heart, lung, liver, and/or kidney disease, in which case the hospital stay is also lengthened. Since the graft must be secured, or sutured, to the remaining portion of the aorta, it is many times difficult to perform the suturing step because the thrombosis present on the remaining portion of the aorta, and that remaining portion of the aorta wall may many times be friable, or easily crumbled.
  • [0008]
    Since many patients having abdominal aortic aneurysms have other chronic illnesses, such as heart, lung, liver, and/or kidney disease, coupled with the fact that many of these patients are older, the average age being approximately 67 years old, these patients are not ideal candidates for such major surgery.
  • [0009]
    More recently, a significantly less invasive clinical approach to aneurysm repair, known as endovascular grafting, has been developed. Parodi, et al. provide one of the first clinical descriptions of this therapy. Parodi, J. C., et al., “Transfemoral Intraluminal Graft Implantation for Abdominal Aortic Aneurysms,” 5 Annals of Vascular Surgery 491 (1991). Endovascular grafting involves the transluminal placement of a prosthetic arterial graft in the endoluminal position (within the lumen of the artery). By this method, the graft is attached to the internal surface of an arterial wall by means of attachment devices (expandable stents), typically one above the aneurysm and a second stent below the aneurysm.
  • [0010]
    Stents permit fixation of a graft to the internal surface of an arterial wall without sewing or an open surgical procedure. Expansion of radially expandable stents is conventionally accomplished by dilating a balloon at the distal end of a balloon catheter. In U.S. Pat. No. 4,776,337, for example, Palmaz describes a balloon-expandable stent for endovascular treatments. Also known are self-expanding stents, such as described in U.S. Pat. No. 4,655,771 to Wallsten.
  • [0011]
    Notwithstanding the foregoing, there remains a need for a transluminally implantable endovascular prosthesis, such as for spanning an abdominal aortic aneurysm. Preferably, the tubular prosthesis can be self expanded at the site to treat the abdominal aortic aneurysm.
  • SUMMARY OF THE INVENTION
  • [0012]
    There is provided in accordance with one aspect of the present invention an endoluminal prosthesis. The endoluminal prosthesis comprises a tubular wire support having a proximal end, a distal end and central lumen extending therethrough. The wire support comprises at least a first and a second axially adjacent tubular segments, joined by a connector extending therebetween. The first and second segments and the connector are formed from a single length of wire.
  • [0013]
    In one embodiment, the wire in each segment comprises a series of proximal bends, a series of distal bends, and a series of wall (strut) segments connecting the proximal bends and distal bends to form a tubular segment wall. Preferably, at least one proximal bend on a first segment is connected to at least one corresponding distal bend on a second segment. The connection may be provided by a metal link, a suture, or other connection means known in the art.
  • [0014]
    Preferably, the endoluminal prosthesis further comprises a polymeric layer such as a tubular PTFE sleeve, on the support.
  • [0015]
    In accordance with another aspect of the present invention, there is provided a method of making an endoluminal prosthesis. The method comprises the steps of providing a length of wire, and forming the wire into two or more zig zag sections, each zig zag section connected by a link. The formed wire is thereafter rolled about an axis to produce a series of tubular elements positioned along the axis such that each tubular element is connected to the adjacent tubular element by a link. Preferably, the method further comprises the step of positioning a tubular polymeric sleeve concentrically on at least a portion of the endoluminal prosthesis.
  • [0016]
    In accordance with another aspect of the present invention, there is provided a multizone endoluminal prosthesis. The multizone prosthesis comprises a tubular wire support having a proximal end, a distal end and a central lumen extending therethrough. The wire support comprises at least a first and a second axially adjacent tubular segments, joined by a connector extending therebetween. The first tubular segment has a different radial strength than the second tubular segment. In one embodiment, the prosthesis further comprises a third tubular segment. At least one of the tubular segments has a different radial strength than the other two tubular segments. In another embodiment, a proximal end of the prosthesis is self expandable to a greater diameter than a central region of the prosthesis.
  • [0017]
    In accordance with another aspect of the present invention, there is provided an endoluminal prosthesis. The prosthesis comprises an elongate flexible wire, formed into a plurality of axially adjacent tubular segments spaced along an axis. Each tubular segment comprises a zig zag section of wire, having a plurality of proximal bends and distal bends, with the wire continuing between each adjacent tubular segment creating an integral structural support system throughout the longitudinal length of the device. The prothesis is radially collapsible into a first, reduced cross sectional configuration for implantation into a body lumen, and self expandable to a second, enlarged cross sectional configuration at a treatment site in a body lumen.
  • [0018]
    Preferably, the prosthesis further comprises an outer tubular sleeve surrounding at least a portion of the prosthesis. One or more lateral perfusion ports may be provided through the tubular sleeve.
  • [0019]
    In one embodiment, the prosthesis has an expansion ratio of at least about 1:5, and, preferably at least about 1:6. The prosthesis in another embodiment has an expanded diameter of at least about 20 mm in an unconstrained expansion, and the prosthesis is implantable using a catheter no greater than about 16 French. Preferably, the prosthesis has an expanded diameter of at least about 25 mm, and is implantable on a delivery device having a diameter of no more than about 16 French.
  • [0020]
    In accordance with a further aspect of the present invention, there is provided a method of implanting an endoluminal vascular prosthesis. The method comprises the steps of providing a self expandable endoluminal vascular prosthesis, having a proximal end, a distal end, and a central lumen extending therethrough. The prosthesis is expandable from a first, reduced diameter to a second, enlarged diameter. The prosthesis is mounted on a catheter, such that when the prosthesis is in the reduced diameter configuration on the catheter, the catheter diameter through the prosthesis is no more than about 16 French. The catheter is thereafter introduced into the body lumen and positioned such that the prosthesis is at a treatment site in the body lumen. The prosthesis is released at the treatment site, such that it expands from the first diameter to the second diameter, wherein the second diameter is at least about 20 mm.
  • [0021]
    Further features and advantages of the present invention will become apparent to those of ordinary skill in the art in view of the disclosure herein, when considered together with the attached drawings and claims.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0022]
    FIG. 1 is a schematic representation of an endoluminal vascular prosthesis in accordance with the present invention, positioned within a symmetric abdominal aortic aneurysm.
  • [0023]
    FIG. 2 is an exploded view of an endoluminal vascular prosthesis in accordance with the present invention, showing a self expandable wire support structure separated from an outer tubular sleeve.
  • [0024]
    FIG. 3 is a plan view of a formed wire useful for rolling about an axis into a multi-segment support structure in accordance with the present invention.
  • [0025]
    FIG. 4 is an enlarged detail view of a portion of the formed wire illustrated in FIG. 3.
  • [0026]
    FIG. 5 is a cross sectional view taken along the lines 5-5 of FIG. 4.
  • [0027]
    FIG. 6 is an alternate cross sectional view taken along the lines 5-5 of FIG. 4.
  • [0028]
    FIG. 7 is a fragmentary view of an alternate wire layout in accordance with a further aspect of the present invention.
  • [0029]
    FIG. 8 is an elevational view of a crosslinked wire layout in accordance with the present invention.
  • [0030]
    FIG. 8A is a plan view of a formed wire layout useful for forming the crosslinked embodiment of FIG. 8.
  • [0031]
    FIG. 9 is a fragmentary view of an alternate wire layout in accordance with a further aspect of the present invention.
  • [0032]
    FIG. 10 is a fragmentary view of an alternate wire layout in accordance with a further aspect of the present invention.
  • [0033]
    FIG. 11 is a fragmentary view of an apex in accordance with one aspect of the present invention.
  • [0034]
    FIG. 12 is a fragmentary view of an alternate embodiment of an apex in accordance with the present invention.
  • [0035]
    FIG. 13 is a further embodiment of an apex in accordance with the present invention.
  • [0036]
    FIG. 14 is a fragmentary view of a further wire layout in accordance with the present invention.
  • [0037]
    FIG. 15 is a fragmentary view of a further wire layout in accordance with the present invention.
  • [0038]
    FIG. 16 is a fragmentary view of a further wire layout in accordance with the present invention.
  • [0039]
    FIG. 17 is a schematic illustration of a delivery catheter in accordance with the present invention, positioned within an abdominal aortic aneurysm.
  • [0040]
    FIG. 18 is an illustration as in FIG. 17, with the endoluminal prosthesis partially deployed from the delivery catheter.
  • [0041]
    FIG. 19 is a cross sectional view taken along the lines 19-19 of FIG. 17.
  • [0042]
    FIG. 20 is a detailed fragmentary view of a tapered wire embodiment in accordance with a further aspect of the present invention.
  • [0043]
    FIG. 21 is a schematic representation of the abdominal aortic anatomy, with an endoluminal vascular prosthesis of the present invention positioned within each of the right renal artery and the right common iliac.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • [0044]
    Referring to FIG. 1, there is disclosed a schematic representation of the abdominal part of the aorta and its principal branches. In particular, the abdominal aorta 30 is characterized by a right renal artery 32 and left renal artery 34. The large terminal branches of the aorta are the right and left common iliac arteries 36 and 38. Additional vessels (e.g., second lumbar, testicular, inferior mesenteric, middle sacral) have been omitted for simplification. A generally symmetrical aneurysm 40 is illustrated in the infrarenal portion of the diseased aorta An expanded endoluminal vascular prosthesis 42, in accordance with the present invention, is illustrated spanning the aneurysm 40. Although features of the endoluminal vascular prosthesis of the present invention can be modified for use in a bifurcation aneurysm, such as the common iliac bifurcation, the endoluminal prosthesis of the present invention will be described herein primarily in terms of its application in the straight segment of the abdominal aorta, or Thoracic or iliac arteries.
  • [0045]
    The endoluminal vascular prosthesis 42 includes a polymeric sleeve 44 and a tubular wire support 46, which are illustrated in situ in FIG. 1. The sleeve 44 and wire support 46 are more readily visualized in the exploded view shown in FIG. 2. The endoluminal prosthesis 42 illustrated and described herein depicts an embodiment in which the polymeric sleeve 44 is situated concentrically outside of the tubular wire support 46. However, other embodiments may include a sleeve situated instead concentrically inside the wire support or on both of the inside and the outside of the wire support. Alternatively, the wire support may be embedded within a polymeric matrix which makes up the sleeve. Regardless of whether the sleeve 44 is inside or outside the wire support 46, the sleeve may be attached to the wire support by any of a variety of means, including laser bonding, adhesives, clips, sutures, dipping or spraying or others, depending upon the composition of the sleeve 44 and overall graft design.
  • [0046]
    The polymeric sleeve 44 may be formed from any of a variety of synthetic polymeric materials, or combinations thereof, including PTFE, PE, PET, Urethane, Dacron, nylon, polyester or woven textiles. Preferably, the sleeve material exhibits relatively low inherent elasticity, or low elasticity out to the intended enlarged diameter of the wire cage 46. The sleeve material preferably has a thin profile, such as no larger than about 0.002 inches to about 0.005 inches.
  • [0047]
    In a preferred embodiment of the invention, the material of sleeve 44 is sufficiently porous to permit ingrowth of endothelial cells, thereby providing more secure anchorage of the prosthesis and potentially reducing flow resistance, sheer forces, and leakage of blood around the prosthesis. Porosity in polymeric sleeve materials may be estimated by measuring water permeability as a function of hydrostatic pressure, which will preferably range from about 3 to 6 psi.
  • [0048]
    The porosity characteristics of the polymeric sleeve 44 may be either homogeneous throughout the axial length of the prosthesis 42, or may vary according to the axial position along the prosthesis 42. For example, referring to FIGS. 1 and 2, different physical properties will be called upon at different axial positions along the prosthesis 42 in use. At least a proximal portion 55 and a distal portion 59 of the prosthesis 42 will seat against the native vessel wall, proximally and distally of the aneurysm. In these proximal and distal portions, the prosthesis preferably encourages endothelial growth, or, at least, permits endothelial growth to infiltrate portions of the prosthesis in order to enhance anchoring and minimize leakage. A central portion 57 of the prosthesis spans the aneurysm, and anchoring is less of an issue. Instead, minimizing blood flow through the prosthesis wall becomes a primary objective. Thus, in a central zone 57 of the prosthesis 42, the polymeric sleeve 44 may either be nonporous, or provided with pores of no greater than about 60% to 80%.
  • [0049]
    A multi-zoned prosthesis 42 may also be provided in accordance with the present invention by positioning a tubular sleeve 44 on a central portion 57 of the prosthesis, such that it spans the aneurysm to be treated, but leaving a proximal attachment zone 55 and a distal attachment zone 59 of the prosthesis 42 having exposed wires from the wire support 46. In this embodiment, the exposed wires 46 are positioned in contact with the vessel wall both proximally and distally of the aneurysm, such that the wire, over time, becomes embedded in cell growth on the interior surface of the vessel wall.
  • [0050]
    In one embodiment of the prosthesis 42, the sleeve 44 and/or the wire support 46 is tapered, having a relatively larger expanded diameter at the proximal end 50 compared to the distal end 52. The tapered design may allow the prosthesis to conform better to the natural decreasing distal cross section of the vessel, to reduce the risk of graft migration and potentially create better flow dynamics.
  • [0051]
    The tubular wire support 46 is preferably formed from a continuous single length of round (shown in FIG. 5) or flattened (shown in FIG. 6) wire. The wire support 46 is preferably formed in a plurality of discrete segments 54, connected together and oriented about a common axis. Each pair of adjacent segments 54 is connected by a connector 66 as will be discussed. The connectors 66 collectively produce a generally axially extending backbone which adds axial strength to the prosthesis 42. Adjacent segments can be connected both by the backbone, as well as by other structures, including circumferentially extending sutures 56 (illustrated in FIGS. 1 and 2), solder joints, wire loops and any of a variety of interlocking relationships. The suture can be made from any of a variety of biocompatible polymeric materials or alloys, such as nylon, polypropylene, or stainless steel. Other means of securing the segments 54 to one another are discussed below (see FIG. 8).
  • [0052]
    The segmented configuration of the tubular wire support 46 facilitates a great deal of flexibility. Each segment 54, though joined to adjacent segments, may be independently engineered to yield desired parameters. Each segment may range in axial length from about 0.3 to about 5 cm. Generally, the shorter their length the greater the radial strength. An endoluminal prosthesis may include from about 1 to about 50 segments, preferably from about 3 to about 10 segments. For example, while a short graft patch, in accordance with the invention, may comprise only 2 segments and span a total of 2 to 3 cm, a complete graft may comprise 4 or more segments and span the entire aortic aneurysm. In addition to the flexibility and other functional benefits available through employment of different length segments, further flexibility can be achieved through adjustments in the number, angle, or configuration of the wire bends associated with the tubular support. Potential bend configurations are discussed in greater detail below (see FIGS. 4-16).
  • [0053]
    A variety of additional advantages can be achieved through the multi-segment configuration of the present invention. For example, referring to FIG. 2, the wire cage 46 is dividable into a proximal zone 55, a central zone 57 and a distal zone 59. As has been discussed, the wire cage 46 can be configured to taper from a relatively larger diameter in the proximal zone 55 to a relatively smaller diameter in the distal zone 59. In addition, the wire cage 46 can have a transitional tapered and or stepped diameter within a given zone.
  • [0054]
    The cage 46 can also be provided with a proximal zone 55 and distal zone 59 that have a larger relative expanded diameter than the central zone 57, as illustrated in FIG. 2. This configuration may desirably resist migration of the prosthesis within the vessel. The proximal zone 55 and/or distal zone 59 can be left without an outer covering 44, with the outer sleeve 44 covering only the central zone 57. This permits the proximal and distal zones 55, 59 to be in direct contact with tissue proximally and distal to the lesion, which may facilitate endothelial cell growth.
  • [0055]
    In addition to having differing expanded diameters in different zones of the prosthesis 42, different zones can be provided with a different radial expansion force, such as ranging from about 0.2 lbs to about 0.8 lbs. In one embodiment, the proximal zone 55 is provided with a greater radial force than the central zone 57 and/or distal zone 59. The greater radial force can be provided in any of a variety of manners discussed elsewhere herein, such as through the use of an additional one or two or three or more proximal bends 60, distal bends 62 and wall sections 64 compared to a reference segment 54 in the central zone 57 or distal zone 59. Alternatively, additional spring force can be achieved in the proximal zone 55 through the use of the same number of proximal bends 60 as in the rest of the prosthesis, but with a heavier gauge wire. Radial force beyond the expanded diameter limit of the central zone 57 can be achieved by tightening the suture 56 as illustrated in FIG. 2 such that the central zone 57 is retained under compression even in the expanded configuration. By omitting a suture at the proximal end and/or distal end of the prosthesis, the proximal end and distal end will flair radially outwardly to a fully expanded configuration as illustrated in FIG. 2.
  • [0056]
    The wire may be made from any of a variety of different alloys, such as elgiloy, nitinol or MP35N, or other alloys which include nickel, titanium, tantalum, or stainless steel, high Co—Cr alloys or other temperature sensitive materials. For example, an alloy comprising Ni 15%, Co 40%, Cr 20%, Mo 7% and balance Fe may be used. The tensile strength of suitable wire is generally above about 300 K psi and often between about 300 and about 340 K psi for many embodiments. In one embodiment, a Chromium-Nickel-Molybdenum alloy such as that marketed under the name Conichrom (Fort Wayne Metals, Ind.) has a tensile strength ranging from 300 to 320 K psi, elongation of 3.5-4.0% and breaking load at approximately 80 lbs to 70 lbs. The wire may be treated with a plasma coating and be provided with/without coating such as: PTFE, Teflon, Perlyne and Drugs.
  • [0057]
    In addition to segment length and bend configuration, discussed above, another determinant of radial strength is wire gauge. The radial strength, measured at 50% of the collapsed profile, preferably ranges from about 0.2 lb to 0.8 lb, and generally from about 0.4 lb to about 0.5 lb. or more. Preferred wire diameters in accordance with the present invention, range from about 0.004 inches to about 0.020 inches. More preferably, the wire diameters range from about 0.006 inches to about 0.018 inches. In general, the greater the wire diameter, the greater the radial strength for a given wire layout. Thus, the wire gauge can be varied depending upon the application of the finished graft, in combination with/or separate from variation in other design parameters (such as the number of struts, or proximal bends 60 and distal bends 62 per segment), as will be discussed. A wire diameter of approximately 0.018 inches may be useful in a graft having four segments each having 2.5 cm length per segment, each segment having six struts intended for use in the aorta, while a smaller diameter such as 0.006 inches might be useful for a 0.5 cm segment graft having 5 struts per segment intended for the iliac artery. The length of cage 42 could be as long as about 28 cm.
  • [0058]
    In one embodiment of the present invention, the wire diameter is tapered from the proximal to distal ends. Alternatively, the wire diameter may be tapered incrementally or stepped down, or stepped up, depending on the radial strength requirements of each particular clinical application. In one embodiment, intended for the abdominal aortic artery, the wire has a cross section of about 0.018 inches in the proximal zone 55 and the wire tapers down to a diameter of about 0.006 inches in the distal zone 59 of the graft 42. End point dimensions and rates of taper can be varied widely, within the spirit of the present invention, depending upon the desired clinical performance.
  • [0059]
    Referring to FIG. 3, there is illustrated a plan view of the single formed wire used for rolling about a longitudinal axis to produce a four segment tubular wire support. The formed wire exhibits distinct segments, each corresponding to an individual tubular segment 54 in the tubular support (see FIGS. 1 and 2).
  • [0060]
    Each segment has a repeating pattern of proximal bends 60 connected to corresponding distal bends 62 by wall sections 64 which extend in a generally zig zag configuration when the segment 54 is radially expanded Each segment 54 is connected to the adjacent segment 54 through a connector 66, except at the terminal ends of the graft. The connector 66 in the illustrated embodiment comprises two wall sections 64 which connect a proximal bend 60 on a first segment 54 with a distal bend 62 on a second, adjacent segment 54. The connector 66 may additionally be provided with a connector bend 68, which may be used to impart increased radial strength to the graft and/or provide a tie site for a circumferentially extending suture.
  • [0061]
    Referring to FIG. 4, there is shown an enlarged view of the wire support illustrating a connector 66 portion between adjacent segments 54. In the embodiment shown in FIG. 4, a proximal bend 60 comprises about a 180 degree arc, having a radial diameter of (w) (Ranging from 0.070 to 0.009 inches), depending on wire diameter followed by a relatively short length of parallel wire spanning an axial distance of d1. The parallel wires thereafter diverge outwardly from one another and form the strut sections 64, or the proximal half of a connector 66. At the distal end of the strut sections 64, the wire forms a distal bend 62, preferably having identical characteristics as the proximal bend 60, except being concave in the opposite direction. The axial direction component of the distance between the apices of the corresponding proximal and distal bends 60, 62 is referred to as (d) and represents the axial length of that segment. The total expanded angle defined by the bend 60 and the divergent strut sections 64 is represented by α. Upon compression to a collapsed state, such as when the graft is within the deployment catheter, the angle α is reduced to α′. In the expanded configuration, α is generally within the range of from about 35° to about 45°. The expanded circumferential distance between any two adjacent distal bends 62 (or proximal bends 60) is defined as (s).
  • [0062]
    In general, the diameter W of each proximal bend 60 or distal bend 62 is within the range of from about 0.009 inches to about 0.070 inches depending upon the wire diameter. Diameter W is preferably as small as possible for a given wire diameter and wire characteristics. As will be appreciated by those of skill in the art, as the distance W is reduced to approach two times the cross section of the wire, the bend 60 or 62 will exceed the elastic limit of the wire, and radial strength of the finished segment will be lost. Determination of a minimum value for W, in the context of a particular wire diameter and wire material, can be readily determined through routine experimentation by those of skill in the art. Similarly, although at least some distance of d1 is desired, from the apex to the first bend in the wall section 64, the distance d1 is preferably minimized within the desired radial strength performance requirements. As d1 increases, it may disadvantageously increase the collapsed profile of the graft.
  • [0063]
    As will be appreciated from FIG. 3 and 4, the sum of the distances (s) in a plane transverse to the longitudinal axis of the finished graft will correspond to the circumference of the finished graft in that plane. For a given circumference, the number of proximal bends 60 or distal bends 62 is directly related to the distance (s) in the corresponding plane. Preferably, the finished graft in any single transverse plane will have from about 3 to about 10 (s) dimensions, preferably from about 4 to about 8 (s) dimensions and, more preferably, about 5 or 6 (s) dimensions for an aortic application. Each (s) dimension corresponds to the distance between any two adjacent bends 60-60 or 62-62 as will be apparent from the discussion herein. Each segment 54 can thus be visualized as a series of triangles extending circumferentially around the axis of the graft, defined by a proximal bend 60 and two distal bends 62 or the reverse.
  • [0064]
    By modifying wire support parameters (such as d, d1, s, alpha and alpha′), the manufacturer enjoys tremendous design control with respect to the total axial length, axial and radial flexibility, radial force and expansion ratios, and consequently prosthesis performance. For example, an increase in the dimension (w) translates directly into an increased collapsed profile since the circumference of the collapsed profile can be no smaller than the sun of the distances (w) in a given transverse plane. Similarly, an increase in the number of proximal bends 60 in a given segment may increase radial strength, but will similarly increase the collapsed profile. Since the primary radial force comes from the proximal bends 60 and distal bends 62, the wall sections 64 act as a lever arm for translating that force into radial strength. As a consequence, decreasing the length of strut sections 64 for a given number of proximal bends 60 will increase the radial strength of the segment but call for additional segments to maintain overall graft length. Where a minimal entry profile is desired, radial strength is best accomplished by decreasing the length of wall sections 64 rather than increasing the number of proximal bends 60. On the other hand, increasing the number of (shorter) segments 54 in a given overall length graft will increase the degree of axial shortening upon radial expansion of the graft. Thus, in an embodiment where axial shortening is to be avoided, increased radial strength may be optimized through selection of wire material or wire gauge and other parameters, while minimizing the number of total segments in the graft. Other geometry consequences of the present invention will be apparent to those of skill in the art in view of the disclosure herein.
  • [0065]
    In one embodiment of the type illustrated in FIG. 8A, w is about 2.0 mm±1 mm for a 0.018 inch wire diameter. D1 is about 3 mm±1 mm, d is about 20 mm±1 mm, c is about 23 mm±1 mm, g is about 17 mm,±1 mm, a is about 3 mm±1 mm and b is about 3 mm±1 mm. Specific dimensions for all of the foregoing variables can be varied considerably, depending upon the desired wire configuration, in view of the disclosure herein.
  • [0066]
    Referring to FIG. 7, there is shown an alternative wire layout having a plurality of radiussed bends 70 in one or more sections of strut 64 which may be included to provide additional flex points to provide enhanced fluid dynamic characteristics and maintain the tubular shape.
  • [0067]
    In another embodiment of the wire support, illustrated in FIG. 8, each pair of adjacent proximal and distal segments, 76 and 78, may be joined by crosslinking of the corresponding proximal and distal bends. Thus, a proximal bend 60 from a distal segment 78 is connected to the corresponding distal bend 62 of a proximal segment 76, thereby coupling the proximal segment 76 and distal segment 78. The connection between corresponding proximal bends 60 and distal bends 62 can be accomplished in any of a variety of ways as will be apparent to those of skill in the art in view of the disclosure herein. In the illustrated embodiment, the connection is accomplished through the use of a link 72. Link 72 may be a loop of metal such as stainless steel, a suture, a welded joint or other type of connection. Preferably, link 72 comprises a metal loop or ring which permits pivotable movement of a proximal segment 76 with respect to a distal segment 78.
  • [0068]
    In one example of an endoluminal vascular prosthesis in accordance with the present invention, the proximal segment 76 is provided with six distal bends 62. The corresponding distal segment 78 is provided with six proximal bends 60 such that a one to one correspondence exists. A link 72 may be provided at each pair of corresponding bends 60, 62, such that six links 72 exist in a plane transverse to the longitudinal axis of the graft at the interface between the proximal segment 76 and the distal segment 78. Alternatively, links 72 can be provided at less than all of the corresponding bends, such as at every other bend, every third bend, or only on opposing sides of the graft. The distribution of the links 72 in any given embodiment can be selected to optimize the desired flexibility characteristics and other performance criteria in a given design.
  • [0069]
    The use of connectors such as cross link 72 enables improved tracking of the graft around curved sections of the vessel. In particular, the wire cage 46 as illustrated in FIG. 8 can be bent around a gentle curve, such that it will both retain the curved configuration and retain patency of the central lumen extending axially therethrough. The embodiment illustrated in FIG. 2 may be more difficult to track curved anatomy while maintaining full patency of the central lumen. The ability to maintain full patency while extending around a curve may be desirable in certain anatomies, such as where the aorta fails to follow the linear infrarenal path illustrated in FIG. 1.
  • [0070]
    Referring to FIG. 8 a, there is illustrated a plan view of a formed wire useful for rolling about an axis to produce a multi-segmented support structure of the type illustrated in FIG. 8. In general, the formed wire of FIG. 8 a is similar to that illustrated in FIG. 3. However, whereas any given pair of corresponding distal bends 62 and proximal bends 60 of the embodiment of FIG. 3 overlap in the axial direction to facilitate threading a circumferential suture therethrough, the corresponding distal bend 62 and proximal bend 60 of the embodiment illustrated in FIG. 8 a may abut end to end against each other or near each other as illustrated in FIG. 8 to receive a connector 72 thereon.
  • [0071]
    The appropriate axial positioning of a distal bend 62 with respect to a corresponding proximal bend 60 can be accomplished in a variety of ways, most conveniently by appropriate formation of the connector bend 68 between adjacent segments of the wire cage.
  • [0072]
    FIGS. 9-16 illustrate alternative bend configurations in accordance with the present invention. FIG. 9 shows one embodiment having the proximal and distal bends as eyelets, but the connector bend 68, remaining in the usual configuration. The embodiment illustrated in FIG. 10 has the proximal and distal bends as well as the connector bend in the eyelet configuration. Various eyelet designs in accordance with the present invention are shown in greater detail in FIGS. 11-13, including a double-looped circular eyelet (FIG. 11), a double-looped triangular eyelet (FIG. 12), and a single-looped triangular eyelet (FIG. 13). The eyelets can be used to receive a circumferentially extending suture or wire as has been described.
  • [0073]
    Additional embodiments of the wire configuration are illustrated in FIGS. 14-16. FIG. 14 shows an embodiment of the proximal 60 and distal 62 bends in which double bends are employed to increase the flexion. Alternatively, FIG. 15 shows triangular bends having a more pronounced length (d1) of parallel wire, and accordingly shorter wall sections 64. Another embodiment of the proximal and distal bends is shown in FIG. 16, wherein the triangular bends include additional flexion points in the form of wall segment bends 70.
  • [0074]
    Referring to FIG. 17 and 18, a deployment device and method in accordance with a preferred embodiment of the present invention are illustrated. A delivery catheter 80, having a dilator tip 82, is advanced along guidewire 84 until the (anatomically) proximal end 50 of the collapsed endoluminal vascular prosthesis 86 is positioned between the renal arteries 32 and 34 and the aneurysm 40. The collapsed prosthesis in accordance with the present invention has a diameter in the range of about 2 to about 10 mm. Preferably, the diameter of the collapsed prosthesis is in the range of about 3 to 6 mm (12 to 18 French). More preferably, the delivery catheter including the prosthesis will be 16 F, or 15 F or 14 F or smaller.
  • [0075]
    The prosthesis 86 is maintained in its collapsed configuration by the restraining walls of the tubular delivery catheter 80, such that removal of this restraint would allow the prosthesis to self expand. Radiopaque marker material may be incorporated into the delivery catheter 80, and/or the prosthesis 86, at least at both the proximal and distal ends, to facilitate monitoring of prosthesis position. The dilator tip 82 is bonded to an internal catheter core 92, as illustrated in FIG. 18, wherein the internal catheter core 92 and the partially expanded prosthesis 88 are revealed as the outer sheath of the delivery catheter 80 is retracted. The internal catheter core 92 is also depicted in the cross-sectional view in FIG. 19.
  • [0076]
    As the outer sheath is retracted, the collapsed prosthesis 86 remains substantially fixed axially relative to the internal catheter core 92 and consequently, self-expands at a predetermined vascular site as illustrated in FIG. 18. Continued retraction of the outer sheath results in complete deployment of the graft. After deployment, the expanded endoluminal vascular prosthesis has radially self-expanded to a diameter anywhere in the range of about 20 to 40 mm, corresponding to expansion ratios of about 1:2 to 1:20. In a preferred embodiment, the expansion ratios range from about 1:4 to 1:8, more preferably from about 1:4 to 1:6.
  • [0077]
    In addition to, or in place of, the outer sheath described above, the prosthesis 86 may be maintained in its collapsed configuration by a restraining lace, which may be woven through the prosthesis or wrapped around the outside of the prosthesis in the collapsed reduced diameter. Following placement of the prosthesis at the treatment site, the lace can be proximally retracted from the prosthesis thereby releasing it to self expand at the treatment site. The lace may comprise any of a variety of materials, such as sutures, strips of PTFE, FEP, polyester fiber, and others as will be apparent to those of skill in the art in view of the disclosure herein. The restraining lace may extend proximally through a lumen in the delivery catheter or outside of the catheter to a proximal control. The control may be a pull tab or ring, rotatable reel, slider switch or other structure for permitting proximal retraction of the lace. The lace may extend continuously throughout the length of the catheter, or may be joined to another axially moveable element such as a pull wire.
  • [0078]
    In general, the expanded diameter of the graft in accordance with the present invention can be any diameter useful for the intended lumen or hollow organ in which the graft is to be deployed. For most arterial vascular applications, the expanded size will be within the range of from about 10 to about 40 mm. Abdominal aortic applications will generally require a graft having an expanded diameter within the range of from about 20 to about 28 mm, and, for example, a graft on the order of about 45 mm may be useful in the thoracic artery. The foregoing dimensions refer to the expanded size of the graft in an unconstrained configuration, such as on the table. In general, the graft will be positioned within an artery having a slightly smaller interior cross section than the expanded size of the graft. This enables the graft to maintain a slight positive pressure against the wall of the artery, to assist in retention of the graft during the period of time prior to endothelialization of the polymeric sleeve 44.
  • [0079]
    The radial force exerted by the proximal segment 94 of the prosthesis against the walls of the aorta 30 provides a seal against the leakage of blood around the vascular prosthesis and tends to prevent axial migration of the deployed prosthesis. As discussed above, this radial force can be modified as required through manipulation of various design parameters, including the axial length of the segment and the bend configurations. In another embodiment of the present invention, radial tension can be enhanced at the proximal, upstream end by changes in the wire gauge as illustrated in FIG. 20. Note that the wire gauge increases progressively along the wall segments 64 from T1 at the proximal bends 60 to T2 at the distal bends 62. Consequently, the radial flex exerted by the distal bends 62 is greater than that exerted by the proximal bends 60 and the radial tension is thereby increased at the proximal end 50 of the prosthesis. T1 may range from about 0.001 to 0.01 inches whereas T2 may range from about 0.01 to 0.03 inches.
  • [0080]
    An alternative embodiment of the wire layout which would cause the radial tension to progressively decrease from the proximal segments to the distal segments, involves a progressive or step-wise decrease in the wire gauge throughout the entire wire support, from about 0.01 to 0.03 inches at the proximal end to about 0.002 to 0.01 inches at the distal end. Such an embodiment, may be used to create a tapered prosthesis. Alternatively, the wire gauge may be thicker at both the proximal and distal ends, in order to insure greater radial tension and thus, sealing capacity. Thus, for instance, the wire gauge in the proximal and distal segments may about 0.01 to 0.03 inches, whereas the intervening segments may be constructed of thinner wire, in the range of about 0.001 to 0.01 inches.
  • [0081]
    Referring to FIG. 21, there is illustrated two alternative deployment sites for the endoluminal vascular prosthesis 42 of the present invention. For example, a symmetrical aneurysm 33 is illustrated in the right renal artery 32. An expanded endoluminal vascular prosthesis 42, in accordance with the present invention, is illustrated spanning that aneurysm 33. Similarly, an aneurysm of the right common iliac 37 is shown, with a prosthesis 42 deployed to span the iliac aneurysm 37.
  • [0082]
    Referring to FIG. 22, there is illustrated a modified embodiment of the endovascular prosthesis 96 in accordance with the present invention. In the embodiment illustrated in FIG. 22, the endovascular prosthesis 96 is provided with a wire cage 46 having six axially aligned segments 54. As with the previous embodiments, however, the endovascular prosthesis 96 may be provided with anywhere from about 2 to about 10 or more axially spaced or adjacent segments 54, depending upon the clinical performance objectives of the particular embodiment.
  • [0083]
    The wire support 46 is provided with a tubular polymeric sleeve 44 as has been discussed. In the present embodiment, however, one or more lateral perfusion ports or openings are provided in the polymeric sleeve 44, such as a right renal artery perfusion port 98 and a left renal artery perfusion port 100 as illustrated.
  • [0084]
    Perfusion ports in the polymeric sleeve 44 may be desirable in embodiments of the endovascular prosthesis 96 in a variety of clinical contexts. For example, although FIGS. 1 and 22 illustrate a generally symmetrical aneurysm 40 positioned within a linear infrarenal portion of the abdominal aorta, spaced axially apart both from bilaterally symmetrical right and left renal arteries and bilaterally symmetrical right and left common iliacs, both the position and symmetry of the aneurysm 40 as well as the layout of the abdominal aortic architecture may differ significantly from patient to patient. As a consequence, the endovascular prosthesis 96 may need to extend across one or both of the renal arteries in order to adequately anchor the endovascular prosthesis 96 and/or span the aneurysm 40. The provision of one or more lateral perfusion ports enables the endovascular prosthesis 96 to span the renal arteries while permitting perfusion therethrough, thereby preventing “stent jailing” of the renals. Lateral perfusion through the endovascular prosthesis 96 may also be provided, if desired, for a variety of other arteries including the second lumbar, testicular, inferior mesenteric, middle sacral, and alike as will be well understood to those of skill in the art.
  • [0085]
    The endovascular prosthesis 96 is preferably provided with at least one, and preferably two or more radiopaque markers, to facilitate proper positioning of the prosthesis 96 within the artery. In an embodiment having perfusion ports 98 and 100 such as in the illustrated design, the prosthesis 96 should be properly aligned both axially and rotationally, thereby requiring the ability to visualize both the axial and rotational position of the device. Alternatively, provided that the delivery catheter design exhibits sufficient torque transmission, the rotational orientation of the graft maybe coordinated with an indexed marker on the proximal end of the catheter, so that the catheter may be rotated and determined by an external indicium of rotational orientation to be appropriately aligned with the right and left renal arteries.
  • [0086]
    In an alterative embodiment, the polymeric sleeve 44 extends across the aneurysm 40, but terminates in the infrarenal zone. In this embodiment, a proximal zone 55 on the prosthesis 96 comprises a wire cage 46 but no polymeric sleeve 44. In this embodiment, the prosthesis 96 still accomplishes the anchoring function across the renal arteries, yet does not materially interfere with renal perfusion. Thus, the polymeric sleeve 44 may cover anywhere from about 50% to about 100% of the axial length of the prosthesis 96 depending upon the desired length of uncovered wire cage 46 such as for anchoring and/or lateral perfusion purposes. In particular embodiments, the polymeric sleeve 44 may cover within the range of from about 70% to about 80%, and, in one four segment embodiment having a single exposed segment, 75%, of the overall length of the prosthesis 96. The uncovered wire cage 46 may reside at only a single end of the prosthesis 96, such as for traversing the renal arteries. Alternatively, exposed portions of the wire cage 46 may be provided at both ends of the prosthesis such as for anchoring purposes.
  • [0087]
    In a further alternative, a two part polymeric sleeve 44 is provided. A first distal part spans the aneurysm 40, and has a proximal end which terminates distally of the renal arteries. A second, proximal part of the polymeric sleeve 44 is carried by the proximal portion of the wire cage 46 which is positioned superiorly of the renal arteries. This leaves an annular lateral flow path through the side wall of the vascular prosthesis 96, which can be axially aligned with the renal arteries, without regard to rotational orientation.
  • [0088]
    The axial length of the gap between the proximal and distal segments of polymeric sleeve 44 can be adjusted, depending upon the anticipated cross sectional size of the ostium of the renal artery, as well as the potential axial misalignment between the right and left renal arteries. Although the right renal artery 32 and left renal artery 34 are illustrated in FIG. 22 as being concentrically disposed on opposite sides of the abdominal aorta, the take off point for the right or left renal arteries from the abdominal aorta may be spaced apart along the abdominal aorta as will be familiar to those of skill in the art. In general, the diameter of the ostium of the renal artery measured in the axial direction along the abdominal aorta falls within the range of from about 7 cm to about 20 cm for a typical adult patient.
  • [0089]
    Clinical and design challenges, which are satisfied by the present invention, include providing a sufficient seal between the upstream end of the vascular prosthesis and the arterial wall, providing a sufficient length to span the abdominal aortic aneurysm, providing sufficient wall strength or support across the span of the aneurysm, and providing a sufficient expansion ratio, such that a minimal percutaneous axis diameter may be utilized for introduction of the vascular prosthesis in its collapsed configuration.
  • [0090]
    Prior art procedures presently use a 7 mm introducer (18 French) which involves a surgical procedure for introduction of the graft delivery device. In accordance with the present invention, the introduction profile is significantly reduced. Embodiments of the present invention can be constructed having a 16 French or 15 French or 14 French or smaller profile (e.g. 34 mm) thereby enabling placement of the endoluminal vascular prosthesis of the present invention by way of a percutaneous procedure. In addition, the endoluminal vascular prosthesis of the present invention does not require a post implantation balloon dilatation, can be constructed to have minimal axial shrinkage upon radial expansion, and avoids the disadvantages associated with nitinol grafts.
  • [0091]
    While a number of preferred embodiments of the invention and variations thereof have been described in detail, other modifications and methods of using and medical applications for the same will be apparent to those of skill in the art. Accordingly, it should be understood that various applications, modifications, and substitutions may be made of equivalents without departing from the spirit of the invention or the scope of the claims.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2127903 *May 5, 1936Aug 23, 1938Davis & Geck IncTube for surgical purposes and method of preparing and using the same
US2990605 *Jan 30, 1957Jul 4, 1961Demsyk PaulMethod of forming artificial vascular members
US3029819 *Jul 30, 1959Apr 17, 1962J L McateeArtery graft and method of producing artery grafts
US3096560 *Nov 21, 1958Jul 9, 1963William J LiebigProcess for synthetic vascular implants
US3805301 *Jul 28, 1972Apr 23, 1974Meadox Medicals IncTubular grafts having indicia thereon
US3953566 *Jul 3, 1973Apr 27, 1976W. L. Gore & Associates, Inc.Process for producing porous products
US4187390 *Jun 21, 1977Feb 5, 1980W. L. Gore & Associates, Inc.Porous products and process therefor
US4497074 *May 30, 1979Feb 5, 1985Agence National De Valorisation De La Recherche (Anvar)Organ prostheses
US4501263 *Mar 31, 1982Feb 26, 1985Harbuck Stanley CMethod for reducing hypertension of a liver
US4503568 *Nov 25, 1981Mar 12, 1985New England Deaconess HospitalSmall diameter vascular bypass and method
US4592754 *Sep 9, 1983Jun 3, 1986Gupte Pradeep MSurgical prosthetic vessel graft and catheter combination and method
US4816028 *Jul 1, 1987Mar 28, 1989Indu KapadiaWoven vascular graft
US4840940 *Oct 21, 1987Jun 20, 1989Sottiurai Vikrom SMethod for reducing the occurrence of distal anastomotic intimal hyperplasia using fractionated heparin
US4907336 *Sep 9, 1988Mar 13, 1990Cook IncorporatedMethod of making an endovascular stent and delivery system
US4922905 *May 28, 1987May 8, 1990Strecker Ernst PDilatation catheter
US4994071 *May 22, 1989Feb 19, 1991Cordis CorporationBifurcating stent apparatus and method
US5019090 *Sep 1, 1988May 28, 1991Corvita CorporationRadially expandable endoprosthesis and the like
US5078726 *Apr 9, 1990Jan 7, 1992Kreamer Jeffry WGraft stent and method of repairing blood vessels
US5104399 *Mar 9, 1988Apr 14, 1992Endovascular Technologies, Inc.Artificial graft and implantation method
US5108424 *Jan 28, 1991Apr 28, 1992Meadox Medicals, Inc.Collagen-impregnated dacron graft
US5133732 *Mar 22, 1989Jul 28, 1992Medtronic, Inc.Intravascular stent
US5178634 *Sep 24, 1991Jan 12, 1993Wilson Ramos MartinezAortic valved tubes for human implants
US5197976 *Sep 16, 1991Mar 30, 1993Atrium Medical CorporationManually separable multi-lumen vascular graft
US5275622 *Jul 13, 1990Jan 4, 1994Harrison Medical Technologies, Inc.Endovascular grafting apparatus, system and method and devices for use therewith
US5282824 *Jun 15, 1992Feb 1, 1994Cook, IncorporatedPercutaneous stent assembly
US5282860 *Oct 8, 1992Feb 1, 1994Olympus Optical Co., Ltd.Stent tube for medical use
US5304200 *Jan 13, 1993Apr 19, 1994Cordis CorporationWelded radially expandable endoprosthesis and the like
US5314444 *Apr 2, 1993May 24, 1994Cook IncorporatedEndovascular stent and delivery system
US5314472 *Oct 1, 1991May 24, 1994Cook IncorporatedVascular stent
US5316023 *Jan 8, 1992May 31, 1994Expandable Grafts PartnershipMethod for bilateral intra-aortic bypass
US5330500 *Oct 17, 1991Jul 19, 1994Song Ho YSelf-expanding endovascular stent with silicone coating
US5383892 *Nov 6, 1992Jan 24, 1995Meadox FranceStent for transluminal implantation
US5387235 *Oct 21, 1992Feb 7, 1995Cook IncorporatedExpandable transluminal graft prosthesis for repair of aneurysm
US5397355 *Jul 19, 1994Mar 14, 1995Stentco, Inc.Intraluminal stent
US5405377 *Feb 21, 1992Apr 11, 1995Endotech Ltd.Intraluminal stent
US5423886 *Aug 23, 1993Jun 13, 1995Sorin Biomedica S.P.A.Cyclically deformable haemocompatible and biocompatible devices coated with biocompatible carbonaceous material
US5425765 *Jun 25, 1993Jun 20, 1995Tiefenbrun; JonathanSurgical bypass method
US5489295 *May 21, 1993Feb 6, 1996Endovascular Technologies, Inc.Endovascular graft having bifurcation and apparatus and method for deploying the same
US5496365 *Jul 15, 1994Mar 5, 1996Sgro; Jean-ClaudeAutoexpandable vascular endoprosthesis
US5507767 *Jan 15, 1992Apr 16, 1996Cook IncorporatedSpiral stent
US5507771 *Apr 24, 1995Apr 16, 1996Cook IncorporatedStent assembly
US5522880 *Jun 22, 1994Jun 4, 1996Barone; Hector D.Method for repairing an abdominal aortic aneurysm
US5522881 *Jun 28, 1994Jun 4, 1996Meadox Medicals, Inc.Implantable tubular prosthesis having integral cuffs
US5522883 *Feb 17, 1995Jun 4, 1996Meadox Medicals, Inc.Endoprosthesis stent/graft deployment system
US5591197 *Mar 14, 1995Jan 7, 1997Advanced Cardiovascular Systems, Inc.Expandable stent forming projecting barbs and method for deploying
US5591229 *Jun 6, 1995Jan 7, 1997Parodi; Juan C.Aortic graft for repairing an abdominal aortic aneurysm
US5593417 *Nov 27, 1995Jan 14, 1997Rhodes; Valentine J.Intravascular stent with secure mounting means
US5609625 *Dec 10, 1993Mar 11, 1997Endovascular Technologies, Inc.Endovascular graft having bifurcation and apparatus and method for deploying the same
US5609627 *Oct 4, 1994Mar 11, 1997Boston Scientific Technology, Inc.Method for delivering a bifurcated endoluminal prosthesis
US5628783 *May 12, 1994May 13, 1997Endovascular Technologies, Inc.Bifurcated multicapsule intraluminal grafting system and method
US5628788 *Nov 7, 1995May 13, 1997Corvita CorporationSelf-expanding endoluminal stent-graft
US5632772 *Nov 13, 1995May 27, 1997Corvita CorporationExpandable supportive branched endoluminal grafts
US5641373 *Apr 17, 1995Jun 24, 1997Baxter International Inc.Method of manufacturing a radially-enlargeable PTFE tape-reinforced vascular graft
US5643339 *Aug 6, 1993Jul 1, 1997William Cook Europe A/SProsthetic device for sustaining a blood-vessel or hollow organ lumen
US5647857 *Mar 16, 1995Jul 15, 1997Endotex Interventional Systems, Inc.Protective intraluminal sheath
US5716365 *Jun 5, 1995Feb 10, 1998Boston Scientific Technologies, Inc.Bifurcated endoluminal prosthesis
US5716393 *May 20, 1995Feb 10, 1998Angiomed Gmbh & Co. Medizintechnik KgStent with an end of greater diameter than its main body
US5718724 *Jun 5, 1995Feb 17, 1998Boston Scientific Technology, Inc.Bifurcated endoluminal prosthesis
US5720776 *Jun 7, 1995Feb 24, 1998Cook IncorporatedBarb and expandable transluminal graft prosthesis for repair of aneurysm
US5723004 *Jan 31, 1996Mar 3, 1998Corvita CorporationExpandable supportive endoluminal grafts
US5733325 *May 6, 1996Mar 31, 1998C. R. Bard, Inc.Non-migrating vascular prosthesis and minimally invasive placement system
US5746766 *Apr 2, 1997May 5, 1998Edoga; John K.Surgical stent
US5746776 *Aug 20, 1996May 5, 1998Creative Products Resource, Inc.Dry-cleaning kit for in-dryer use
US5749880 *Jul 27, 1995May 12, 1998Impra, Inc.Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
US5755770 *Jan 31, 1995May 26, 1998Boston Scientific CorporatiionEndovascular aortic graft
US5755771 *Nov 3, 1995May 26, 1998Divysio Solutions UlcExpandable stent and method of delivery of same
US5769884 *Jun 27, 1996Jun 23, 1998Cordis CorporationControlled porosity endovascular implant
US5769885 *Aug 16, 1996Jun 23, 1998Endovascular Technologies, Inc.Bifurcated multicapsule intraluminal grafting system and method
US5769887 *Jan 17, 1997Jun 23, 1998Endotex Interventional Systems, Inc.Delivery catheter and graft for aneurysm repair
US5855599 *Sep 2, 1997Jan 5, 1999Sitek, Inc.Silicon micro machined occlusion implant
US5860998 *Nov 25, 1996Jan 19, 1999C. R. Bard, Inc.Deployment device for tubular expandable prosthesis
US5891193 *Apr 11, 1997Apr 6, 1999C.R. Bard, Inc.Non-migrating vascular prosthesis and minimally invasive placement system therefor
US5902334 *Apr 11, 1997May 11, 1999C.R. Bard, Inc.Method and apparatus for recapture of hooked endoprosthesis
US5928279 *Jul 3, 1996Jul 27, 1999Baxter International Inc.Stented, radially expandable, tubular PTFE grafts
US6027779 *May 24, 1994Feb 22, 2000W. L. Gore & Associates, Inc.Thin-wall polytetrafluoroethylene tube
US6027811 *Jun 7, 1995Feb 22, 2000W. L. Gore & Associates, Inc.Thin-wall intraluminal graft
US6030415 *Jan 28, 1998Feb 29, 2000Endovascular Technologies, Inc.Bell-bottom modular stent-graft
US6039749 *Apr 15, 1997Mar 21, 2000Endovascular Systems, Inc.Method and apparatus for deploying non-circular stents and graftstent complexes
US6039755 *Feb 5, 1997Mar 21, 2000Impra, Inc., A Division Of C.R. Bard, Inc.Radially expandable tubular polytetrafluoroethylene grafts and method of making same
US6039758 *Dec 22, 1997Mar 21, 2000Endovascular Technologies, Inc.Method for intraluminally deploying a bifurcated graft
US6051020 *Oct 29, 1997Apr 18, 2000Boston Scientific Technology, Inc.Bifurcated endoluminal prosthesis
US6070589 *Aug 1, 1997Jun 6, 2000Teramed, Inc.Methods for deploying bypass graft stents
US6074398 *Jan 13, 1998Jun 13, 2000Datascope Investment Corp.Reduced diameter stent/graft deployment catheter
US6077296 *Mar 4, 1998Jun 20, 2000Endologix, Inc.Endoluminal vascular prosthesis
US6077297 *Jan 12, 1998Jun 20, 2000C. R. Bard, Inc.Non-migrating vascular prosthesis and minimally invasive placement system therefor
US6090128 *Feb 20, 1997Jul 18, 2000Endologix, Inc.Bifurcated vascular graft deployment device
US6168610 *Feb 16, 2000Jan 2, 2001Endovascular Systems, Inc.Method for endoluminally excluding an aortic aneurysm
US6187036 *Dec 11, 1998Feb 13, 2001Endologix, Inc.Endoluminal vascular prosthesis
US6192944 *Apr 24, 2000Feb 27, 2001Prodesco, Inc.Method of forming a textile member with undulating wire
US6197049 *Feb 17, 1999Mar 6, 2001Endologix, Inc.Articulating bifurcation graft
US6210422 *Feb 16, 2000Apr 3, 2001Endologix, Inc.Bifurcated vascular graft deployment device
US6261316 *Mar 11, 1999Jul 17, 2001Endologix, Inc.Single puncture bifurcation graft deployment system
US6379382 *Mar 13, 2000Apr 30, 2002Jun YangStent having cover with drug delivery capability
US6508835 *Nov 28, 2000Jan 21, 2003Endologix, Inc.Endoluminal vascular prosthesis
US6689157 *Dec 21, 2001Feb 10, 2004Endologix, Inc.Dual wire placement catheter
US6733523 *Jun 26, 2001May 11, 2004Endologix, Inc.Implantable vascular graft
US7520895 *Apr 8, 2002Apr 21, 2009Endologix, Inc.Self expanding bifurcated endovascular prosthesis
US7691135 *Apr 6, 2010Endologix, Inc.Single puncture bifurcation graft deployment system
US20070078506 *Oct 12, 2006Apr 5, 2007Mccormick PaulMethod and apparatus for decompressing aneurysms
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7892277May 3, 2006Feb 22, 2011Endologix, Inc.Self expanding bifurcated endovascular prosthesis
US8147535Jul 25, 2005Apr 3, 2012Endologix, Inc.Bifurcation graft deployment catheter
US8236040Apr 11, 2008Aug 7, 2012Endologix, Inc.Bifurcated graft deployment systems and methods
US8357192Mar 11, 2011Jan 22, 2013Endologix, Inc.Bifurcated graft deployment systems and methods
US8377110Apr 8, 2004Feb 19, 2013Endologix, Inc.Endolumenal vascular prosthesis with neointima inhibiting polymeric sleeve
US8764812Jan 18, 2013Jul 1, 2014Endologix, Inc.Bifurcated graft deployment systems and methods
US8945202Apr 28, 2010Feb 3, 2015Endologix, Inc.Fenestrated prosthesis
US20050228480 *Apr 8, 2004Oct 13, 2005Douglas Myles SEndolumenal vascular prosthesis with neointima inhibiting polymeric sleeve
Classifications
U.S. Classification623/1.16
International ClassificationA61F2/82, A61F2/90, A61F2/06, A61F2/86, A61F2/966, A61F2/07, A61F2/954, A61F2/958
Cooperative ClassificationA61F2/90, A61F2002/828, A61F2002/072, A61F2/07, A61F2/958, A61F2002/061, A61F2/966, A61F2/86, A61F2002/067, A61F2002/075, A61F2/954, A61F2230/0054, A61F2220/0075, A61F2220/0016, A61F2220/005
European ClassificationA61F2/966, A61F2/07, A61F2/86